Lonza is a world-leading Contract Development and Manufacturing Organization (CDMO) dedicated to serving the healthcare industry. Founded in Switzerland in 1897, Lonza partners with customers ranging from emerging biotechnology companies to global pharmaceutical organizations to transform scientific innovation into life-saving and life-enhancing therapies. With more than 125 years of experience and a global network spanning over 30 sites worldwide, Lonza provides integrated solutions across the entire product lifecycle, from early development through commercial manufacturing. Its capabilities include cell line development, process development, analytical and regulatory support, drug substance and drug product manufacturing, helping customers accelerate development, reduce risk, and successfully bring innovative medicines to patients around the world.